Products
Fulvestrant is commercially available as a solution for injection (Faslodex, generic). It has been approved in many countries since 2004.
Structure and properties
Fulvestrant (C32H47F5O3S, Mr = 606.8 g/mol) exists as a white powder that is practically insoluble in water.
Effects
Fulvestrant (ATC L02BA03) has antiestrogenic properties. It is an antagonist at the estrogen receptor.
Indications
Breast carcinoma
